- Home
- ZNTL vs SOL Comparison
ZNTL vs SOL Comparison
Compare ZNTL & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- SOL
- Stock Information
- Founded
- ZNTL 2014
- SOL 2005
- Country
- ZNTL United States
- SOL United States
- Employees
- ZNTL N/A
- SOL N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- ZNTL Health Care
- SOL Technology
- Exchange
- ZNTL Nasdaq
- SOL Nasdaq
- Market Cap
- ZNTL 105.8M
- SOL 98.5M
- IPO Year
- ZNTL 2020
- SOL 2008
- Fundamental
- Price
- ZNTL $1.49
- SOL $1.88
- Analyst Decision
- ZNTL Buy
- SOL Strong Buy
- Analyst Count
- ZNTL 7
- SOL 2
- Target Price
- ZNTL $8.46
- SOL $4.50
- AVG Volume (30 Days)
- ZNTL 805.4K
- SOL 117.5K
- Earning Date
- ZNTL 11-11-2025
- SOL 08-19-2025
- Dividend Yield
- ZNTL N/A
- SOL N/A
- EPS Growth
- ZNTL N/A
- SOL N/A
- EPS
- ZNTL N/A
- SOL N/A
- Revenue
- ZNTL $26,865,000.00
- SOL $68,445,000.00
- Revenue This Year
- ZNTL N/A
- SOL N/A
- Revenue Next Year
- ZNTL N/A
- SOL $45.37
- P/E Ratio
- ZNTL N/A
- SOL N/A
- Revenue Growth
- ZNTL N/A
- SOL N/A
- 52 Week Low
- ZNTL $1.01
- SOL $1.04
- 52 Week High
- ZNTL $5.44
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- ZNTL 43.18
- SOL 53.12
- Support Level
- ZNTL $1.60
- SOL $1.81
- Resistance Level
- ZNTL $2.02
- SOL $1.88
- Average True Range (ATR)
- ZNTL 0.13
- SOL 0.03
- MACD
- ZNTL -0.04
- SOL 0.00
- Stochastic Oscillator
- ZNTL 5.36
- SOL 81.33
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.